Thanks to Alisenoc, cancer patients will have high-quality nutritional supplements with novel ingredients and with a wide range of flavors.

With the aim of improving nutritional status
and the quality of life of patients.

Con el objetivo de mejorar el estado nutricional y la calidad de vida de los pacientes.

For its scientific validation, a clinical trial will be carried out with the participation of the following entities:

The Alisenoc project is co-financed by the CDTI with ERDF funds from the European Union.

Certificado ISO 9001:2015